These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28559274)

  • 1. A Lower Baseline CD4/CD8 T-Cell Ratio Is Independently Associated with Immunodiscordant Response to Antiretroviral Therapy in HIV-Infected Subjects.
    Rosado-Sánchez I; Herrero-Fernández I; Álvarez-Ríos AI; Genebat M; Abad-Carrillo MA; Ruiz-Mateos E; Pulido F; González-García J; Montero M; Bernal-Morell E; Vidal F; Leal M; Pacheco YM
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequencies of Th17 cells and IL17a-producing regulatory T-cells preceding the immunodiscordant response to antiretroviral treatment.
    Rosado-Sánchez I; Herrero-Fernández I; Tarancon-Diez L; Moreno S; Iribarren JA; Dalmau D; Vera-Méndez F; Leal M; Pacheco YM
    J Infect; 2018 Jan; 76(1):86-92. PubMed ID: 29079322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery.
    Massanella M; Negredo E; Puig J; Puertas MC; Buzón MJ; Pérez-Álvarez N; Carrillo J; Clotet B; Martínez-Picado J; Blanco J
    AIDS; 2012 Nov; 26(18):2285-93. PubMed ID: 23018435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.
    Wolday D; Legesse D; Kebede Y; Siraj DS; McBride JA; Striker R
    PLoS One; 2020; 15(10):e0240880. PubMed ID: 33091053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.
    Stranford SA; Ong JC; Martinez-Marino B; Busch M; Hecht FM; Kahn J; Levy JA
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):597-602. PubMed ID: 11136234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
    Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I
    Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients.
    Roger PM; Breittmayer JP; Arlotto C; Pugliese P; Pradier C; Bernard-Pomier G; Dellamonica P; Bernard A
    Clin Exp Immunol; 1999 Dec; 118(3):412-6. PubMed ID: 10594560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir.
    Levacher M; Bouscarat F; Landman R; Chau F; Damond F; Gaudebout C; Mathez D; Leibowitch J; Saimot AG; Sinet M
    AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1869-75. PubMed ID: 11118072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.
    Negredo E; Massanella M; Puertas MC; Buzón MJ; Puig J; Pérez-Alvárez N; Pérez-Santiago J; Bonjoch A; Moltó J; Jou A; Echeverría P; Llibre JM; Martínez-Picado J; Clotet B; Blanco J
    J Antimicrob Chemother; 2013 Oct; 68(10):2358-62. PubMed ID: 23677919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic Function Impacts the Peripheral CD4/CD8 Ratio of HIV-Infected Subjects.
    Rosado-Sánchez I; Herrero-Fernández I; Genebat M; Ruiz-Mateos E; Leal M; Pacheco YM
    Clin Infect Dis; 2017 Jan; 64(2):152-158. PubMed ID: 27986677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
    García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
    AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy.
    Ndumbi P; Gillis J; Raboud J; Cooper C; Hogg RS; Montaner JS; Burchell AN; Loutfy MR; Machouf N; Klein MB; Tsoukas C;
    HIV Med; 2014 Mar; 15(3):153-64. PubMed ID: 24304582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery.
    Massanella M; Gómez-Mora E; Carrillo J; Curriu M; Ouchi D; Puig J; Negredo E; Cabrera C; Clotet B; Blanco J
    J Transl Med; 2015 Jul; 13():230. PubMed ID: 26183947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4/CD8 ratio improvement in HIV-1-infected patients receiving dual antiretroviral treatment.
    Monsalvo M; Vallejo A; Fontecha M; Vivancos MJ; Vizcarra P; Casado JL
    Int J STD AIDS; 2019 Jun; 30(7):656-662. PubMed ID: 30961467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.
    Landay AL; Bettendorf D; Chan E; Spritzler J; Schmitz JL; Bucy RP; Gonzalez CJ; Schnizlein-Bick CT; Evans T; Squires KE; Phair JP
    AIDS Res Hum Retroviruses; 2002 Jan; 18(2):95-102. PubMed ID: 11839142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV Reservoir Decay and CD4 Recovery Associated With High CD8 Counts in Immune Restored Patients on Long-Term ART.
    Zhang LX; Jiao YM; Zhang C; Song JW; Fan X; Xu RN; Huang HH; Zhang JY; Wang LF; Zhou CB; Jin L; Shi M; Wang FS
    Front Immunol; 2020; 11():1541. PubMed ID: 32793212
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes.
    Pérez-Santiago J; Ouchi D; Urrea V; Carrillo J; Cabrera C; Villà-Freixa J; Puig J; Paredes R; Negredo E; Clotet B; Massanella M; Blanco J
    AIDS; 2016 Sep; 30(15):2275-87. PubMed ID: 27427875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.
    Serrano-Villar S; Sainz T; Lee SA; Hunt PW; Sinclair E; Shacklett BL; Ferre AL; Hayes TL; Somsouk M; Hsue PY; Van Natta ML; Meinert CL; Lederman MM; Hatano H; Jain V; Huang Y; Hecht FM; Martin JN; McCune JM; Moreno S; Deeks SG
    PLoS Pathog; 2014 May; 10(5):e1004078. PubMed ID: 24831517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mononucleosis syndrome with viro-immunologic parameters similar to those of a primary HIV-1 infection after interruption of highly effective anti-retroviral treatment].
    Orbea Ríos L; Domínguez Castellanos A; Justo Alpañés E
    An Med Interna; 2002 Jun; 19(6):321-2. PubMed ID: 12152394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.